CELFULL to Unveil Pioneering Anti-Aging Technologies

CELFULL to Unveil Pioneering Anti-Aging Technologies


CELFULL to Unveil Pioneering Anti-Aging Technologies

NEW YORK – April 21, 2026 – CELFULL, a innovative drug research and development brand specializing in serious anti-aging interventions, announced today its upcoming exhibition at Vitafoods Europe 2026. The premier global B2B nutraceutical event will take place in Barcelona, Spain, from May 5 to May 7, 2026. Meeting the event’s strict entest thresholds for technological and scientific competitiveness, CELFULL will join over 1,600 top-tier global companies to present its proprietary Celfavor active ingredients delivery technology alongside a series of advanced scientific breakthroughs.

This follows the highly successful debut of the Celfavor Registered NADH product at SupplySide West 2025 in Las Vegas, where the innovation drew significant interest from a wide range of attfinishees and received strong validation from industest professionals for its efficacy and stability.

Image: https://www.globalnewslines.com/uploads/2026/04/7337e81493e77c77c3983848e660e715.jpg

Standing out among exhibitors that typically focus on single avenues like raw materials, traditional pharmaceuticals, or basic supplements, CELFULL leverages a unique “serious medical and consumer medical” dual-track drive model cultivated over 25 years. By utilizing its innovative drug R&D capabilities as its foundation, the company effectively brings clinical-grade technologies to the consumer market. Since launching its tarobtained aging intervention drug research in 2017, CELFULL has developed robust medical pipelines tarobtaining Parkinson’s syndrome, cardiovascular health, and ovarian health.

Image: https://www.globalnewslines.com/uploads/2026/04/b7eabeef224c0bdf80412a2ffa1eb49d.jpg

A focal point of the exhibition will be CELFULL’s Celfavor technology. Initially developed to overcome pharmaceutical pipeline challenges such as gastric acid inactivation and low delivery efficiency, this controlled-release technology has been successfully applied to consumer products through years of iteration. This ensures high-efficacy delivery of active ingredients, perfectly enpowering the brand’s premium NADH applications and other advanced formulations. The company’s scientific and technological research is guided by world-renowned experts, led by biochemist Dr. Juliane Hitzel. CELFULL’s groundbreaking research has been published in prestigious journals, including Nature, Aging Cell, and other.

CELFULL’s competitive edge is protected by a comprehensive global patent portfolio that spans aging intervention substances, preparation technologies, and detection methods. As of December 2025, the company has applied for over 100 invention patents globally, securing 43 authorizations in the United States, China, Japan, Canada, Australia, and other regions. Notably, its patent covering compositions for the prevention and treatment of inflammatory storms fills a critical industest gap.

Beyond proprietary technology, CELFULL is actively building a global scientific ecosystem to push the anti-aging industest toward rigorous standardization. The company is a key collaborator in the world’s largest NMN clinical study on female reproductive health (US clinical registest NCT05305677) and continues to explore AI anti-aging technologies with top experts. At Vitafoods Europe, CELFULL will introduce its “NAD+ high-throughput protein probe technology” and real-world research data, aiming to upgrade the global anti-aging industest standard from “single-ingredient evaluation” to comprehensive “whole life cycle health management”.

Through this exhibition, CELFULL intfinishs not only to demonstrate the depth of its frontline anti-aging science but also to drive a fundamental reconstruction of the industest landscape.

About CELFULL:

CELFULL is a serious anti-aging innovative drug R&D brand with 25 years of deep industest expertise. Operating on a “drugs + supplements” dual-track drive model, CELFULL’s research comprehensively covers the complete chain of aging mechanism research, drug tarobtain identification, and clinical translation to deliver highly effective, scientifically backed health interventions.
Media Contact
Company Name: CELFULL BIO-TECH (USA) Inc.
Contact Person: Maggie Jane
Email: Sfinish Email [http://www.universalpressrelease.com/?pr=celfull-to-unveil-pioneering-antiaging-technologies-and-dualtrack-rd-at-vitafoods-europe-2026]
Countest: United States
Website: https://www.celfull.com

Legal Disclaimer: Information contained on this page is provided by an indepfinishent third-party content provider. GetNews creates no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be rerelocated, please contact retract@swscontact.com

This release was published on openPR.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *